Literature DB >> 21791583

Prevalence of corneal dystrophies in the United States: estimates from claims data.

David C Musch1, Leslie M Niziol, Joshua D Stein, Roheena M Kamyar, Alan Sugar.   

Abstract

PURPOSE: To estimate the prevalence of corneal dystrophies.
METHODS: Records of almost 8 million enrollees in a national managed-care network throughout the United States who had an eye care visit in 2001 to 2009 were searched for a recording of corneal dystrophy on a claim submitted by an ophthalmologist or optometrist from January 1, 2001, through December 31, 2007.
RESULTS: Unique individuals (n = 27,372) received two or more diagnoses of any type of corneal dystrophy, for an overall corneal dystrophy prevalence rate of 897 per million (10⁶) covered lives. Endothelial and anterior corneal dystrophies accounted for most of the reported dystrophies, and granular corneal dystrophy was the least common, being reported in 167 enrollees. Age, sex, and race variations among the various corneal dystrophies were observed. The mean age of those with macular corneal dystrophy (47.3 years) was 15 years younger than the age of those with endothelial dystrophy (62.9 years), and females were most highly represented (68.5%) among those with lattice corneal dystrophy. Hispanics and blacks were underrepresented relative to enrollees undergoing eye care for reasons other than corneal dystrophy. Keratoplasty was most frequently coded among those with lattice dystrophy.
CONCLUSIONS: Although caveats must be considered in using claims data to estimate prevalence in a population, these data provide an indication of corneal dystrophy's prevalence within insured subjects across the United States. Variations in age, sex, and race, within and between the different types of corneal dystrophies, raise questions that warrant further study.

Entities:  

Mesh:

Year:  2011        PMID: 21791583      PMCID: PMC3175990          DOI: 10.1167/iovs.11-7771

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  9 in total

1.  National survey on bullous keratopathy in Japan.

Authors:  Jun Shimazaki; Shiro Amano; Toshihiko Uno; Naoyuki Maeda; Norihiko Yokoi
Journal:  Cornea       Date:  2007-04       Impact factor: 2.651

2.  Posterior polymorphous corneal dystrophy in Czech families maps to chromosome 20 and excludes the VSX1 gene.

Authors:  Rhian Gwilliam; Petra Liskova; Martin Filipec; Stanislav Kmoch; Katerina Jirsova; Elizabeth J Huckle; Catherine L Stables; Shomi S Bhattacharya; Alison J Hardcastle; Panos Deloukas; Neil D Ebenezer
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-12       Impact factor: 4.799

Review 3.  Use of insurance claims databases to evaluate the outcomes of ophthalmic surgery.

Authors:  A L Coleman; H Morgenstern
Journal:  Surv Ophthalmol       Date:  1997 Nov-Dec       Impact factor: 6.048

4.  Central cornea guttata. Incidence in the general population.

Authors:  D W Lorenzetti; M H Uotila; N Parikh; H E Kaufman
Journal:  Am J Ophthalmol       Date:  1967-12       Impact factor: 5.258

5.  Prevalence of and risk factors for cornea guttata in a population-based study in a southwestern island of Japan: the Kumejima study.

Authors:  Akiko Higa; Hiroshi Sakai; Shoichi Sawaguchi; Aiko Iwase; Atsuo Tomidokoro; Shiro Amano; Makoto Araie
Journal:  Arch Ophthalmol       Date:  2011-03

6.  E2-2 protein and Fuchs's corneal dystrophy.

Authors:  Keith H Baratz; Nirubol Tosakulwong; Euijung Ryu; William L Brown; Kari Branham; Wei Chen; Khoa D Tran; Katharina E Schmid-Kubista; John R Heckenlively; Anand Swaroop; Goncalo Abecasis; Kent R Bailey; Albert O Edwards
Journal:  N Engl J Med       Date:  2010-08-25       Impact factor: 91.245

7.  Prevalence and risk factors for cornea guttata in the Reykjavik Eye Study.

Authors:  Gunnar M Zoega; Aya Fujisawa; Hiroshi Sasaki; Akiko Kubota; Kazuyuki Sasaki; Kazuko Kitagawa; Fridbert Jonasson
Journal:  Ophthalmology       Date:  2006-04       Impact factor: 12.079

8.  Macular corneal dystrophy in Iceland. A clinical, genealogic, and immunohistochemical study of 28 patients.

Authors:  F Jonasson; E Oshima; E J Thonar; C F Smith; J H Johannsson; G K Klintworth
Journal:  Ophthalmology       Date:  1996-07       Impact factor: 12.079

Review 9.  The IC3D classification of the corneal dystrophies.

Authors:  Jayne S Weiss; H U Møller; Walter Lisch; Shigeru Kinoshita; Anthony J Aldave; Michael W Belin; Tero Kivelä; Massimo Busin; Francis L Munier; Berthold Seitz; John Sutphin; Cecilie Bredrup; Mark J Mannis; Christopher J Rapuano; Gabriel Van Rij; Eung Kweon Kim; Gordon K Klintworth
Journal:  Cornea       Date:  2008-12       Impact factor: 2.651

  9 in total
  29 in total

1.  Eye Symptom Questionnaire to Evaluate Anterior Eye Health.

Authors:  Maria A Woodward; Nita G Valikodath; Paula Anne Newman-Casey; Leslie M Niziol; David C Musch; Paul P Lee
Journal:  Eye Contact Lens       Date:  2018-11       Impact factor: 2.018

2.  Association of the Gutta-Induced Microenvironment With Corneal Endothelial Cell Behavior and Demise in Fuchs Endothelial Corneal Dystrophy.

Authors:  Viridiana Kocaba; Kishore Reddy Katikireddy; Ilene Gipson; Marianne O Price; Francis W Price; Ula V Jurkunas
Journal:  JAMA Ophthalmol       Date:  2018-08-01       Impact factor: 7.389

Review 3.  Corneal blindness and xenotransplantation.

Authors:  Vladimir Lamm; Hidetaka Hara; Alex Mammen; Deepinder Dhaliwal; David K C Cooper
Journal:  Xenotransplantation       Date:  2014-02-21       Impact factor: 3.907

4.  Establishment of an in vitro monolayer model of macular corneal dystrophy.

Authors:  Sumit Murab; Shibu Chameettachal; Sourabh Ghosh
Journal:  Lab Invest       Date:  2016-10-17       Impact factor: 5.662

5.  Qualitative and Quantitative Analysis of the Corneal Endothelium With Smartphone Specular Microscopy.

Authors:  Michael J Fliotsos; Shiva Deljookorani; Daliya Dzhaber; Subhangi Chandan; Mehrnaz Ighani; Allen O Eghrari
Journal:  Cornea       Date:  2020-07       Impact factor: 2.651

6.  Pilot Study of Audiometric Patterns in Fuchs Corneal Dystrophy.

Authors:  Nicholas S Reed; Jennifer A Deal; Matthew G Huddle; Joshua F Betz; Bethany E Bailey; Elyse J McGlumphy; Allen O Eghrari; S Amer Riazuddin; Frank R Lin; John D Gottsch
Journal:  J Speech Lang Hear Res       Date:  2018-10-26       Impact factor: 2.297

7.  Menadione-Induced DNA Damage Leads to Mitochondrial Dysfunction and Fragmentation During Rosette Formation in Fuchs Endothelial Corneal Dystrophy.

Authors:  Adna Halilovic; Thore Schmedt; Anne-Sophie Benischke; Cecily Hamill; Yuming Chen; Janine Hertzog Santos; Ula V Jurkunas
Journal:  Antioxid Redox Signal       Date:  2016-04-11       Impact factor: 8.401

8.  Fuchs' Endothelial Corneal Dystrophy and RNA Foci in Patients With Myotonic Dystrophy.

Authors:  V Vinod Mootha; Brock Hansen; Ziye Rong; Pradeep P Mammen; Zhengyang Zhou; Chao Xing; Xin Gong
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-09-01       Impact factor: 4.799

9.  Racial/Ethnic Differences in Rates of Penetrating or Endothelial Keratoplasty for Fuchs Endothelial Corneal Dystrophy Among US Medicare Beneficiaries.

Authors:  Michael A Mahr; Keith H Baratz; David O Hodge; Jay C Erie
Journal:  JAMA Ophthalmol       Date:  2016-10-01       Impact factor: 7.389

Review 10.  Diseases of the corneal endothelium.

Authors:  Lauren J Jeang; Curtis E Margo; Edgar M Espana
Journal:  Exp Eye Res       Date:  2021-02-14       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.